{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:04:34Z","timestamp":1788465874482,"version":"build-2803163510"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>To compare the antifungal efficacy of corneal cross-linking (CXL) and voriconazole in experimental <jats:italic>Aspergillus<\/jats:italic> keratitis models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Thirty-nine New Zealand rabbits were divided into three groups: a control group, a voriconazole group (M group), and a voriconazole combined with CXL group (CXL-M group). The ulcer area was measured via slit lamp imaging, the corneal and corneal epithelial thickness, and ulcer depth was measured via anterior segment optical coherence tomography (AS-OCT). The existence time of the hyphae was observed via <jats:italic>in vivo<\/jats:italic> confocal microscopy (IVCM), and the cornea was taken for pathological examination after modeling and at the end of the study to determine the hyphae and corneal repair. The observation times were as follows: at successful modeling and at 1, 4, 7, 14, 21, and 28 days after intervention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the CXL-M group, ulcer area and depth decreased continuously from Day 4 to Day 28 after CXL (all <jats:italic>P<\/jats:italic> &amp;lt; 0.05). In the CXL-M group, ulcer area and depth were smaller than those in the other two groups from Day 4 to Day 21 after CXL (all <jats:italic>P<\/jats:italic> &amp;lt; 0.05, except ulcer area in the CXL-M vs. M group on Day 21). The duration of hyphae in the CXL-M group was significantly shorter than in the other two groups (<jats:italic>P<\/jats:italic> = 0.025). On Day 28, in CXL-M group, corneal thickness was thicker than baseline (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). Meanwhile, in CXL-M group, corneal and corneal epithelial thickness were significantly thinner than in the other two groups (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). The CXL-M group had no complications, such as corneal perforation, at the end of the study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Voriconazole combined with CXL is effective in treating <jats:italic>Aspergillus<\/jats:italic>-infected keratitis. Combined therapy could effectively inhibit <jats:italic>Aspergillus<\/jats:italic>, accelerate corneal repair, and shorten the course of the disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.869429","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T04:31:21Z","timestamp":1656390681000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of Corneal Collagen Cross-Linking and Voriconazole Treatments in Experimental Fungal Keratitis for Aspergillus fumigatus"],"prefix":"10.3389","volume":"9","author":[{"given":"Zhennan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6395840","DOI":"10.1155\/2019\/6395840","article-title":"Fungal keratitis: epidemiology, rapid detection, and antifungal susceptibilities of fusarium and aspergillus isolates from corneal scrapings","volume":"2019","author":"Manikandan","year":"2019","journal-title":"Biomed Res Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s11046-016-0042-3","article-title":"Fungal keratitis in North India: spectrum of agents, risk factors and treatment","volume":"181","author":"Ghosh","year":"2016","journal-title":"Mycopathologia."},{"key":"B3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12281-013-0163-9","article-title":"Review and update on the epidemiology, clinical presentation, diagnosis, and treatment of fungal keratitis","volume":"7","author":"Ng","year":"2013","journal-title":"Curr Fungal Infect Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/myc.12822","article-title":"Fungal Keratitis: An overview of clinical and laboratory aspects","volume":"61","author":"Mahmoudi","year":"2018","journal-title":"Mycoses."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1097\/ICO.0000000000001696","article-title":"Impact of iontophoresis and Pack-Cxl corneal concentrations of antifungals in an in vivo model","volume":"37","author":"Kalkanci","year":"2018","journal-title":"Cornea."},{"key":"B6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12281-013-0150-1","article-title":"Current thoughts in fungal keratitis: diagnosis and treatment","volume":"7","author":"Ansari","year":"2013","journal-title":"Curr Fungal Infect Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.18240\/ijo.2016.11.23","article-title":"Review of clinical and basic approaches of fungal keratitis","volume":"9","author":"Wu","year":"2016","journal-title":"Int J Ophthalmol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0002-9394(02)02220-1","article-title":"Riboflavin\/Ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus","volume":"135","author":"Wollensak","year":"2003","journal-title":"Am J Ophthalmol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/01.icu.0000233954.86723.25","article-title":"Crosslinking treatment of progressive keratoconus: new hope","volume":"17","author":"Wollensak","year":"2006","journal-title":"Curr Opin Ophthalmol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/ICO.0b013e318169d698","article-title":"Ultraviolet a\/Riboflavin corneal cross-linking for infectious keratitis associated with corneal melts","volume":"27","author":"Iseli","year":"2008","journal-title":"Cornea."},{"key":"B11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000456537","article-title":"Corneal cross-linking as a treatment for fungal keratitis associated with corneal melting","volume":"8","author":"Igal","year":"2017","journal-title":"Case Rep Ophthalmol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/bjophthalmol-2014-304944","article-title":"Collagen crosslinking in the management of advanced non-resolving microbial keratitis","volume":"98","author":"Shetty","year":"2014","journal-title":"Br J Ophthalmol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/bjophthalmol-2012-302518","article-title":"Riboflavin\/ultravoilet light-mediated crosslinking for fungal keratitis","volume":"97","author":"Li","year":"2013","journal-title":"Br J Ophthalmol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1111\/aos.13829","article-title":"Comparison of corneal collagen cross-linking (Pack-Cxl) and voriconazole treatments in experimental fungal keratitis","volume":"97","author":"Ozdemir","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/ICO.0000000000000644","article-title":"Corneal Collagen cross-linking for infectious keratitis: a systematic review and meta-analysis","volume":"35","author":"Papaioannou","year":"2016","journal-title":"Cornea."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1167\/iovs.07-1592","article-title":"Antimicrobial Efficacy of Riboflavin\/Uva Combination (365 Nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis","volume":"49","author":"Martins","year":"2008","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3109\/02713683.2015.1088956","article-title":"Evaluation of antifungal efficacy of 01% and 025% Riboflavin with Uva: a Comparative in vitro study","volume":"41","author":"Bilgihan","year":"2016","journal-title":"Curr Eye Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00417-019-04314-1","article-title":"Evaluation of corneal cross-linking as adjuvant therapy for the management of fungal keratitis","volume":"257","author":"Wei","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3928\/1081597X-20141113-06","article-title":"Accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking as a first-line and sole treatment in early fungal keratitis","volume":"30","author":"Tabibian","year":"2014","journal-title":"J Refract Surg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3928\/1081597X-20120921-06","article-title":"Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology","volume":"28","author":"Price","year":"2012","journal-title":"J Refract Surg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/02713683.2010.533810","article-title":"Ocular fungal infections","volume":"36","author":"Kalkanci","year":"2011","journal-title":"Curr Eye Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.micpath.2016.12.013","article-title":"Pathogenesis of microbial keratitis","volume":"104","author":"Lakhundi","year":"2017","journal-title":"Microb Pathog."},{"key":"B23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/00003226-200210000-00002","article-title":"Evaluation of corneal scraping smear examination methods in the diagnosis of bacterial and fungal keratitis: a survey of eight years of laboratory experience","volume":"21","author":"Sharma","year":"2002","journal-title":"Cornea."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1136\/bjo.86.11.1211","article-title":"Aetiology of suppurative corneal ulcers in Ghana and South India, and epidemiology of fungal keratitis","volume":"86","author":"Leck","year":"2002","journal-title":"Br J Ophthalmol."},{"key":"B25","first-page":"205","article-title":"Evaluation of the in vitro antimicrobial properties of ultraviolet a\/riboflavin mediated crosslinking on Candida Albicans and fusarium solani","volume":"7","author":"Sun","year":"2014","journal-title":"Int J Ophthalmol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1021\/tx000020e","article-title":"DNA. Damage induced in cells by \u0393 and Uva radiation as measured by Hplc\/Gc\u2013 Ms and Hplc\u2013 Ec and comet assay","volume":"13","author":"Pouget","year":"2000","journal-title":"Chem Res Toxicol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1562\/2006-03-09-IR-840","article-title":"Photosensitized DNA damage and its protection via a novel mechanism","volume":"83","author":"Hiraku","year":"2007","journal-title":"Photochem Photobiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1529\/biophysj.106.082388","article-title":"Singlet oxygen generation by Uva light exposure of endogenous photosensitizers","volume":"91","author":"Baier","year":"2006","journal-title":"Biophys J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1167\/iovs.09-4013","article-title":"In vitro efficacy of antifungal treatment using Riboflavin\/Uv-a (365 Nm) combination and Amphotericin B","volume":"51","author":"Sauer","year":"2010","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/ICO.0b013e318221cec7","article-title":"Treatment of fungal keratitis from fusarium infection by corneal cross-linking","volume":"31","author":"Galperin","year":"2012","journal-title":"Cornea."},{"key":"B31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12886-018-0727-0","article-title":"Antimicrobial efficacy of corneal cross-linking in vitro and in vivo for fusarium solani: a potential new treatment for fungal keratitis","volume":"18","author":"Zhu","year":"2018","journal-title":"BMC Ophthalmol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1080\/09273948.2020.1770296","article-title":"Therapeutic effect of corneal crosslinking on fungal keratitis: efficacy of corneal collagen crosslinking as an adjuvant therapy for fungal keratitis in a tertiary eye hospital in South India","volume":"29","author":"Jeyalatha Mani","year":"2021","journal-title":"Ocul Immunol Inflamm."},{"key":"B33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ajo.2015.03.024","article-title":"Corneal cross-linking as an adjuvant therapy in the management of recalcitrant deep stromal fungal keratitis: a randomized trial","volume":"160","author":"Uddaraju","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/ceo.12399","article-title":"Evaluation of corneal collagen cross-linking as an additional therapy in mycotic keratitis","volume":"43","author":"Vajpayee","year":"2015","journal-title":"Clin Exp Ophthalmol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1006\/exer.2000.0971","article-title":"Enzymatic, clinical and histologic evaluation of corneal tissues in experimental fungal keratitis in rabbits","volume":"72","author":"Gopinathan","year":"2001","journal-title":"Exp Eye Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/02713680490513182","article-title":"Increased resistance of crosslinked cornea against enzymatic digestion","volume":"29","author":"Spoerl","year":"2004","journal-title":"Curr Eye Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"406850","DOI":"10.1155\/2012\/406850","article-title":"Collagen cross-linking: current status and future directions","volume":"2012","author":"Hovakimyan","year":"2012","journal-title":"J. Ophthalmol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.ophtha.2014.01.011","article-title":"Collagen cross-linking with photoactivated riboflavin (Pack-Cxl) for the treatment of advanced infectious keratitis with corneal melting","volume":"121","author":"Said","year":"2014","journal-title":"Ophthalmology."},{"key":"B39","doi-asserted-by":"publisher","first-page":"9275","DOI":"10.1167\/iovs.11-8155","article-title":"Cross-linking with ultraviolet-a and riboflavin reduces corneal permeability","volume":"52","author":"Stewart","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.98411","volume":"55","author":"Suman","year":"2021","journal-title":"Fungal keratitis: recent advances in diagnosis and treatment. Infect Eye Dis Recent Adv Diagn Treat"},{"key":"B41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.molimm.2014.11.021","article-title":"The crosstalk between Tlr2 and Nod2 in aspergillus fumigatus keratitis","volume":"64","author":"Wu","year":"2015","journal-title":"Mol Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00003226-200401000-00008","article-title":"Keratocyte apoptosis after corneal collagen cross-linking using Riboflavin\/Uva treatment","volume":"23","author":"Wollensak","year":"2004","journal-title":"Cornea."},{"key":"B43","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jcrs.2006.11.015","article-title":"Hydration behavior of porcine cornea crosslinked with riboflavin and ultraviolet A","volume":"33","author":"Wollensak","year":"2007","journal-title":"J Cataract Refract Surg."},{"key":"B44","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ajo.2011.03.023","article-title":"Transient corneal thinning in eyes undergoing corneal cross-linking","volume":"152","author":"Holopainen","year":"2011","journal-title":"Am J Ophthalmol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.869429\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T04:31:26Z","timestamp":1656390686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.869429\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":44,"alternative-id":["10.3389\/fmed.2022.869429"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.869429","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"article-number":"869429"}}